UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008957
Receipt number R000010506
Scientific Title A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.
Date of disclosure of the study information 2012/10/01
Last modified on 2015/12/01 17:45:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.

Acronym

A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.

Scientific Title

A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.

Scientific Title:Acronym

A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.

Region

Japan


Condition

Condition

diffuse diabetic macular edema

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effectiveness at improving visual acuity and decreasing central macular thickness in early vitrectomy for diffuse diabetic macular edema with intravitreal injection of triamcinolone acetonide.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

visual acuity
central macular thickness

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Pars plana vitrectomy and follow up for 24 months.

Interventions/Control_2

Intravitreal injection of triamcinolone acetonide and follow up for 24 months.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Aged 18 years or older.
Diffuse DME(CMT 300microns < determined by OCT).
BCVA between 58 and 74 letters of a ETDRS visual acuity scale.

Key exclusion criteria

Eyes of signs of vitreomacular traction on biomicroscopy or OCT.
Eyes with active proliferative DR.
Eyes with known a history of glaucoma,optic nerve atrophy,vitrectomy,intravitreal injection,subtenon injection.
Eyes with known a history of photocoagulation within 3 months,cataract operation within 6 months.
Patients with any of serious heart disease, cerebrovascular disease,blood disorder, renal failure, malignant tumor, systemic steroids.
Patients with HbA1c 10% or higher, or systolic blood pressure of more than 180 mmHg or diastolic blood pressure more than 110 mmHg.
Patients with known as steroid responder.

Target sample size

162


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Taiji Sakamoto

Organization

Kagoshima University Graduate School of Medical and Dental Science

Division name

Department of Ophthalmology

Zip code


Address

Sakuragaoka 8-35-1, Kagoshima, 890-8520 Japan

TEL

099-275-5402

Email

tsakamot@m3.kufm.kagoshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Taiji Sakamoto

Organization

Kagoshima University Graduate School of Medical and Dental Science

Division name

Department of Ophthalmology

Zip code


Address

Sakuragaoka 8-35-1, Kagoshima, 890-8520 Japan

TEL

099-275-5402

Homepage URL


Email

tsakamot@m3.kufm.kagoshima-u.ac.jp


Sponsor or person

Institute

Kagoshima University Graduate School of Medical and Dental Science

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 09 Month 21 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 09 Month 21 Day

Last modified on

2015 Year 12 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010506


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name